Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

6.6%

8 terminated/withdrawn out of 121 trials

Success Rate

76.5%

-10.1% vs industry average

Late-Stage Pipeline

8%

10 trials in Phase 3/4

Results Transparency

8%

2 of 26 completed trials have results

Key Signals

17 recruiting2 with results6 terminated

Enrollment Performance

Analytics

N/A
46(51.7%)
Phase 2
28(31.5%)
Phase 3
7(7.9%)
Phase 1
5(5.6%)
Phase 4
3(3.4%)
89Total
N/A(46)
Phase 2(28)
Phase 3(7)
Phase 1(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (121)

Showing 20 of 121 trials
NCT07567625Not ApplicableRecruiting

Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)

Role: lead

NCT07687433Phase 2Active Not Recruiting

Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant Therapy for Locally Advanced/Low-Lying Rectal Cancer Requiring Sphincter Preservation

Role: lead

NCT07682220Not ApplicableCompleted

Default Option Nudging Intervention to Improve the Adherence Rates of Cancer Screening

Role: lead

NCT07682376Phase 2Active Not Recruiting

Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Role: lead

NCT07552402Not ApplicableRecruiting

Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer

Role: lead

NCT07632222Phase 1Not Yet Recruiting

High-Protein Diet for Improving Alcoholic Fatty Liver Disease

Role: collaborator

NCT07663071Phase 2Active Not Recruiting

Short-course Radiotherapy Combined With Retlirafusp Alfa and CAPOX Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Prospective, Single-arm, Phase II Clinical Study

Role: lead

NCT07416344Not ApplicableEnrolling By Invitation

A Coronary Computed Tomography Angiography-guided Intervention for High Risk Cardiovascular Disease Population in Rural China

Role: lead

NCT07645209Active Not Recruiting

A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions

Role: lead

NCT07624201Phase 2Not Yet Recruiting

Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer

Role: lead

NCT07163455Not ApplicableRecruiting

Time-Restricted Eating for Weight-Loss Maintenance

Role: lead

NCT07471815Phase 2Active Not Recruiting

Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy

Role: lead

NCT06947148Not ApplicableCompleted

The Impact of Comprehensive Post Hospital Management Based on DHI on Cardiac Function in Patients With HF

Role: lead

NCT06817512Not ApplicableActive Not Recruiting

Ischemic Stroke Nutrition Intervention Study

Role: lead

NCT07035301Not ApplicableCompleted

Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures

Role: lead

NCT06700018Recruiting

Flow Patterns and Stent Thrombosis

Role: collaborator

NCT06975501Not ApplicableActive Not Recruiting

Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity

Role: collaborator

NCT07319455Not ApplicableNot Yet Recruiting

Heart Voice: Starry Journey - A Digital ACT Intervention for ASD Caregivers

Role: lead

NCT04624854Phase 4Completed

Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Role: lead

NCT07229872Phase 2Not Yet Recruiting

A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in the Treatment of Immunodominant pMMR/MSS Metastatic Colorectal Cancer That Has Failed Second-line or Above Treatment

Role: lead